An Immunobridging Study to Evaluate the Neutralizing Antibody Titer in Adults Immunized with Two Doses of Either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901.
- Resource Type
- Article
- Source
- Vaccines; May2022, Vol. 10 Issue 5, p655-655, 9p
- Subject
ANTIBODY titer CLINICAL trials VACCINE effectiveness ADULTS IMMUNE response - Language
- ISSN
- 2076393X